Equol producers can have low leptin levels among prediabetic and diabetic females

Annales d'Endocrinologie

Volumn 75, Issue 1, 2014, Pages 25-28

  Sakane, Naoki ^a   Kotani, Kazuhiko ^a,b   Tsuzaki, Kokoro ^a   Takahashi, Kaoru ^a,c   Usui, Takeshi ^a   Uchiyama, Shigeto ^d   Fujiwara, Shinji ^a,e  

^a NATIONAL HOSPITAL ORGANIZATION KYOTO MEDICAL CENTER   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c Hyogo Health Service Association   (Japan)

^d OTSUKA PHARMACEUTICAL CO LTD   (Japan)

^e Mima City National Health Insurance Koyadaira Clinic   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; EQUOL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEPTIN; TRIACYLGLYCEROL; ADIPOQ PROTEIN, HUMAN; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; ISOFLAVONE DERIVATIVE; LIPID;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; SEX DIFFERENCE; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL; URINE LEVEL; AGE; ANALYSIS; BIOSYNTHESIS; BLOOD; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; EPIDEMIOLOGY; INTESTINE; METABOLISM; MICROBIOLOGY; SEXUAL DEVELOPMENT; SOYBEAN; URINE;

ADIPONECTIN; AGE FACTORS; BLOOD GLUCOSE; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; EQUOL; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; INTESTINES; ISOFLAVONES; LEPTIN; LIPIDS; MALE; PREDIABETIC STATE; SAMPLING STUDIES; SEX CHARACTERISTICS; SMOKING; SOY FOODS;

EID: 84897378306     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ando.2014.01.003     Document Type: Article

References (18)

1. Xu X., Duncan A.M., Wangen K.E., Kurzer M.S. Soy consumption alters endogenous estrogen metabolism in postmenopausal women. Cancer Epidemiol Biomarkers Prev 2000, 9:781-786.
2. Atkinson C., Frankenfeld C.L., Lampe J.W. Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health. Exp Biol Med 2005, 230:155-170.
3. Messina M. A brief historical overview of the past two decades of soy and isoflavone research. J Nutr 2010, 140:S1350-S1354.
4. Kalaiselvan V., Kalaivani M., Vijayakumar A., Sureshkumar K., Venkateskumar K. Current knowledge and future direction of research on soy isoflavones as a therapeutic agents. Pharmacogn Rev 2010, 4:111-117.
5. Usui T., Tochiya M., Sasaki Y., Muranaka K., Yamakage H., Himeno A., et al. Effects of natural S-equol supplements on overweight or obesity and metabolic syndrome in the Japanese, based on sex and equol status. Clin Endocrinol 2013, 78:365-372.
6. Matsubara M., Maruoka S., Katayose S. Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese females. Eur J Endocrinol 2002, 147:173-180.
7. Söderberg S., Zimmet P., Tuomilehto J., Chitson P., Gareeboo H., Alberti K.G., et al. Leptin predicts the development of diabetes in Mauritian men, but not women: a population-based study. Int J Obes 2007, 31:1126-1133.
8. Rachoń D., Vortherms T., Seidlová-Wuttke D., Wuttke W. Effects of dietary equol on body weight gain, intra-abdominal fat accumulation, plasma lipids, and glucose tolerance in ovariectomized Sprague-Dawley rats. Menopause 2007, 14:925-932.
9. Kotani K., Fujiwara S., Tsuzaki K., Sano Y., Sakane N. A gene polymorphism in acetyl-coenzyme A carboxylase beta may be associated with the C-reactive protein level in a prediabetic and diabetic population. Exp Clin Endocrinol Diabetes 2012, 120:59-61.
10. Musso G., Gambino R., Cassader M. Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded?. Diabetes Care 2010, 33:2277-2284.
11. Aggarwal J., Swami G., Kumar M. Probiotics and their effects on metabolic diseases: an update. J Clin Diagn Res 2013, 7:173-177.
12. Panwar H., Rashmi H.M., Batish V.K., Grover S. Probiotics as potential biotherapeutics in the management of type 2 diabetes: prospects and perspectives. Diabetes Metab Res Rev 2013, 29:103-112.
13. Wu J., Oka J., Ezaki J., Ohtomo T., Ueno T., Uchiyama S., et al. Possible role of equol status in the effects of isoflavone on bone and fat mass in postmenopausal Japanese females: a double-blind, randomized, controlled trial. Menopause 2007, 14:866-874.
14. Kishida T., Mizushige T., Ohtsu Y., Ishikawa S., Nagamoto M., Izumi T., et al. Dietary soy isoflavone-aglycone lowers food intake in female rats with and without ovariectomy. Obesity 2008, 16:290-297.
15. Cnop M., Havel P.J., Utzschneider K.M., Carr D.B., Sinha M.K., Boyko E.J., et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 2003, 46:459-469.
16. Grossmann M.E., Cleary M.P. The balance between leptin and adiponectin in the control of carcinogenesis: focus on mammary tumorigenesis. Biochimie 2012, 94:2164-2171.
17. Nakamura K., Fuster J.J., Walsh K. Adipokines: a link between obesity and cardiovascular disease. J Cardiol 2013, pii: S0914-5087(13)00355-9 [Epub ahead of print].
18. Liu W., Tanabe M., Harada K.H., Koizumi A. Levels of urinary isoflavones and lignan polyphenols in Japanese females. Environ Health Prev Med 2013, 18:394-400.